An audio-only dial-in will be available at the following numbers:
Audio-Only Dial Ins:
+1 646 876 9923 (New
York)
+1 301 715 8592 (Washington, D.C.)
+1 312 626 6799
(Chicago)
+1 669 900 6833 (San Jose)
+1 253 215 8782
(Tacoma)
+1 346 248 7799 (Houston)
+1 408 638 0968 (San
Jose)
Webinar ID: 922 4974 9055
For International Dial-Ins, please see our web site at www.ginkgobioworks.com/investors
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The companys platform is enabling biotechnology
applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will
result in Ginkgo, through a parent entity, Ginkgo Bioworks Holdings, Inc., becoming a public company. The transaction is expected to close in the third quarter of 2021, subject to regulatory and shareholder approvals, and other customary closing
conditions. For more information, visit www.ginkgobioworks.com.
ADDITIONAL LEGAL INFORMATION
Forward-Looking Statements Legend
This document contains
certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Ginkgo and Soaring Eagle, including statements regarding the anticipated timing of the Special Meeting and the
consummation of the Business Combination, the services offered by Ginkgo and the markets in which it operates, and Ginkgos projected future results. These forward-looking statements generally are identified by the words believe,
project, expect, anticipate, estimate, intend, strategy, future, potential, opportunity, plan, may,
should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are predictions, projections and other statements about
future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document,
including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of Soaring Eagles securities, (ii) the risk that the transaction may not be
completed by Soaring Eagles business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Soaring Eagle, (iii) the failure to satisfy the